Showing results (681-690 of 1,023) with videos related to

Sort By:
Pageof 103
Annals of Vascular Surgery|September 16, 2018
Outcomes after Lower Extremity Revascularization for Treatment of Critical Limb Ischemia with Tissue Loss in Patients with Chronic Immune-Mediated Inflammatory DiseaseMonica S O'Brien-Irr, Maciej L Dryjski, H Hasan Dosluoglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Significance of FHIT expression in chronic myelogenous leukemiaH M Kantarjian, M Talpaz, S O'Brien, et al.
Cancer|December 18, 2001
Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phaseH M Kantarjian, J Shan, T Smith, et al.
Leukemia Research|April 27, 2000
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemiaF Ravandi-Kashani, S O'Brien, T Manshouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Blood|June 22, 2001
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaS Ibrahim, M Keating, K A Do, et al.
Clinical Pediatrics|January 24, 2012
Peripheral intravenous access in pediatric inpatientsJ Routt Reigart, Katie H Chamberlain, David Eldridge, et al.
Neuroscience Letters|July 10, 1999
Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brainI Hozumi, M Hiraiwa, T Inuzuka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Pageof 103